| Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L MS Kareta, ZM Botello, JJ Ennis, C Chou, F Chédin Journal of Biological Chemistry 281 (36), 25893-25902, 2006 | 259 | 2006 |
| Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein N Nady, A Lemak, JR Walker, GV Avvakumov, MS Kareta, M Achour, ... Journal of Biological Chemistry 286 (27), 24300-24311, 2011 | 234 | 2011 |
| Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis MS Kareta, LL Gorges, S Hafeez, BA Benayoun, S Marro, AF Zmoos, ... Cell stem cell 16 (1), 39-50, 2015 | 219 | 2015 |
| Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates M Mall, MS Kareta, S Chanda, H Ahlenius, N Perotti, B Zhou, SD Grieder, ... Nature 544 (7649), 245-249, 2017 | 204 | 2017 |
| DNMT3L Modulates Significant and Distinct Flanking Sequence Preference for DNA Methylation by DNMT3A and DNMT3B In Vivo BL Wienholz, MS Kareta, AH Moarefi, CA Gordon, PA Ginno, F Chédin PLoS genetics 6 (9), e1001106, 2010 | 167 | 2010 |
| Identification and targeting of long-term tumor-propagating cells in small cell lung cancer NS Jahchan, JS Lim, B Bola, K Morris, G Seitz, KQ Tran, L Xu, F Trapani, ... Cell reports 16 (3), 644-656, 2016 | 88 | 2016 |
| A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research N Nady, J Min, MS Kareta, F Chédin, CH Arrowsmith Trends in Biochemical Sciences 33 (7), 305-313, 2008 | 88 | 2008 |
| Global DNA methylation remodeling during direct reprogramming of fibroblasts to neurons C Luo, QY Lee, O Wapinski, R Castanon, JR Nery, M Mall, MS Kareta, ... Elife 8, e40197, 2019 | 69 | 2019 |
| A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation O El-Maarri, MS Kareta, T Mikeska, T Becker, A Diaz-Lacava, J Junen, ... Human molecular genetics 18 (10), 1755-1768, 2009 | 67 | 2009 |
| YAP-mediated recruitment of YY1 and EZH2 represses transcription of key cell-cycle regulators S Hoxha, A Shepard, S Troutman, H Diao, JR Doherty, M Janiszewska, ... Cancer research 80 (12), 2512-2522, 2020 | 50 | 2020 |
| Crosstalk between stem cell and cell cycle machineries MS Kareta, J Sage, M Wernig Current Opinion in Cell Biology 37, 68-74, 2015 | 45 | 2015 |
| Pro-neuronal activity of Myod1 due to promiscuous binding to neuronal genes QY Lee, M Mall, S Chanda, B Zhou, KS Sharma, K Schaukowitch, ... Nature cell biology 22 (4), 401-411, 2020 | 43 | 2020 |
| Tandem E2F Binding Sites in the Promoter of the p107 Cell Cycle Regulator Control p107 Expression and Its Cellular Functions DL Burkhart, SE Wirt, AF Zmoos, MS Kareta, J Sage PLoS genetics 6 (6), e1001003, 2010 | 41 | 2010 |
| Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype E Voigt, M Wallenburg, H Wollenzien, E Thompson, K Kumar, J Feiner, ... Molecular Cancer Research 19 (12), 2015-2025, 2021 | 12 | 2021 |
| Somatic pluripotent genes in tissue repair, developmental disease, and cancer H Wollenzien, E Voigt, MS Kareta SPG biomed 1 (2), 2018 | 9 | 2018 |
| Transcriptional regulation of miR-30a by YAP impacts PTPN13 and KLF9 levels and Schwann cell proliferation A Shepard, S Hoxha, S Troutman, D Harbaugh, MS Kareta, JL Kissil Journal of Biological Chemistry 297 (2), 2021 | 4 | 2021 |
| Cancer origins—genetics rules the day MS Kareta, J Sage Science 362 (6410), 30-31, 2018 | 3 | 2018 |
| Sox2 is an oncogenic driver of small cell lung cancer E Voigt, H Wollenzien, J Feiner, E Thompson, M Vande Kamp, MS Kareta BioRxiv, 657924, 2019 | 2 | 2019 |
| Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer H Wollenzien, Y Afeworki Tecleab, R Szczepaniak-Sloane, A Restaino, ... Molecular Cancer Research 21 (9), 892-907, 2023 | 1 | 2023 |
| Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2 J Doherty, V Mandati, MA González Rodriguez, S Troutman, A Shepard, ... Neuro-Oncology Advances 4 (1), vdac072, 2022 | 1 | 2022 |
